Real-world effectiveness and safety of dapagliflozin therapy added to a GLP1 receptor agonist in patients with type 2 diabetes
Gorgojo-Martínez, J.J, Serrano-Moreno, C, Sanz-Velasco, A, Feo-Ortega, G, Almodóvar-Ruiz, F
Published in Nutrition, metabolism, and cardiovascular diseases (01.02.2017)
Published in Nutrition, metabolism, and cardiovascular diseases (01.02.2017)
Get full text
Journal Article